Rocket Lab Faces Development Hurdle with Neutron Rocket Program

Rocket Lab USA US7731221062

Shares of Rocket Lab USA experienced volatility, trading between $80.50 and $92.30, as the company navigates contrasting narratives. While celebrating a significant operational milestone, a technical setback in a key development program introduced uncertainty for investors.

The company's operational backbone remains robust. Rocket Lab successfully completed its 80th launch of the Electron rocket, deploying two satellites for new customer Open Cosmos into a 1,050-kilometer orbit. Dubbed "The Cosmos Will See You Now," this first 2026 mission underscores the technical maturity and reliability of the established Electron system. This recurring launch business provides critical ongoing revenue, serving as a financial stabilizer while newer projects are in development.

Setback Emerges in Neutron Qualification

The market movement was primarily triggered by an incident within the Neutron rocket program. During a recent nighttime pressure test designed to evaluate structural limits, a first-stage tank experienced a failure. Company officials stated that such tests are intentionally pushed to failure points as a standard part of the qualification process for new spacecraft components.

Initial assessments indicate no major damage to the test stand or surrounding infrastructure. Manufacturing of the next first-stage tank is already underway. An updated timeline for the medium-lift Neutron rocket, a project central to Rocket Lab's future growth strategy, is expected to be announced in February alongside the quarterly financial report.

Analyst Outlook and Market Implications

The test failure has raised questions about potential delays for the Neutron, highlighting that the path to a heavy-lift launch vehicle may be more challenging than anticipated. Despite this, some analysts maintain a positive longer-term view. In mid-January, Morgan Stanley upgraded Rocket Lab's rating to "Overweight," setting a price target of $105. This assessment was predicated on the successful parallel advancement of both the Electron and Neutron programs.

The current situation illustrates Rocket Lab's balancing act: leveraging a proven, revenue-generating launch service while managing the inherent risks and technical hurdles of developing a larger, more powerful rocket. The market's reaction reflects the heightened sensitivity to any obstacles facing the growth-critical Neutron project. All eyes will be on the company's February update for a clearer development schedule.